CoChat

Epidemic and Emerging Coronaviruses (Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome)

Open access
Hui, David S. · 2017 · Clinics in Chest Medicine
Cited by 153

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Bats are the natural reservoirs of severe acute respiratory syndrome (SARS)-like coronaviruses (CoVs) and likely the reservoir of Middle East respiratory syndrome (MERS)-CoV. The clinical features of SARS-CoV infection and MERS-CoV infection are similar but MERS-CoV infection progresses to respiratory failure more rapidly. Although the estimated pandemic potential of MERS-CoV is lower than that of SARS-CoV, the case fatality rate of MERS is higher. The transmission route and the possibility of other intermediary animal sources remain uncertain among many sporadic primary cases. Clinical trial options for MERS-CoV infection include monotherapy and combination therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ccm.2016.11.007

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 129

  1. Zumla, 2016, Coronaviruses - drug discovery and therapeutic options, Nat Rev Drug Discov, 15, 327, 10.1038/nrd.2015.37 · DOI · Paper page
  2. Ksiazek, 2003, A novel coronavirus associated with severe acute respiratory syndrome, N Engl J Med, 348, 1953, 10.1056/NEJMoa030781 · DOI · Paper page
  3. Kuiken, 2003, Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome, Lancet, 362, 263, 10.1016/S0140-6736(03)13967-0 · DOI · Paper page
  4. Lee, 2003, A major outbreak of severe acute respiratory syndrome in Hong Kong, N Engl J Med, 348, 1986, 10.1056/NEJMoa030685 · DOI · Paper page
  5. Tsang, 2003, A cluster of cases of severe acute respiratory syndrome in Hong Kong, N Engl J Med, 348, 1977, 10.1056/NEJMoa030666 · DOI · Paper page
  6. Zhao, 2003, Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China, J Med Microbiol, 52, 715, 10.1099/jmm.0.05320-0 · DOI · Paper page
  7. Xu, 2004, Epidemiologic clues to SARS origin in China, Emerg Infect Dis, 10, 1030, 10.3201/eid1006.030852 · DOI · Paper page
  8. Zhong, 2003, Epidemiology and cause of severe acute respiratory syndrome in Guangdong, People’s Republic of China, in Feb 2003, Lancet, 362, 1353, 10.1016/S0140-6736(03)14630-2 · DOI · Paper page
  9. Du, 2004, Analysis on the characteristics of blood serum Ab-IgG detective result of severe acute respiratory syndrome patients in Guangzhou, China, Zhonghua Liu Xing Bing Xue Za Zhi, 25, 925
  10. Guan, 2003, Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China, Science, 302, 276, 10.1126/science.1087139 · DOI · Paper page
  11. Wang, 2005, SARS-CoV infection in a restaurant from palm civet, Emerg Infect Dis, 11, 1860, 10.3201/eid1112.041293 · DOI · Paper page
  12. Song, 2005, Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human, Proc Natl Acad Sci U S A, 102, 2430, 10.1073/pnas.0409608102 · DOI · Paper page
  13. Lau, 2005, Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats, Proc Natl Acad Sci, 102, 14040, 10.1073/pnas.0506735102 · DOI · Paper page
  14. Li, 2005, Bats are natural reserviors of SARS-like coronaviruses, Science, 310, 676, 10.1126/science.1118391 · DOI · Paper page
  15. Chan, 2004, Persistent infection of SARS coronavirus in colonic cells in vitro, J Med Virol, 74, 1, 10.1002/jmv.20138 · DOI
  16. Simmons, 2005, Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry, Proc Natl Acad Sci, 102, 11876, 10.1073/pnas.0505577102 · DOI · Paper page
  17. Law, 2005, The 3a protein of severe acute respiratory syndrome-associated coronavirus induces apoptosis in Vero E6 cells, J Gen Virol, 86, 1921, 10.1099/vir.0.80813-0 · DOI · Paper page
  18. Tan, 2004, Over expression of 7a, a protein specifically encoded by the severe acute respiratory syndrome coronavirus, induces apoptosis via a caspase-dependent pathway, J Virol, 78, 14043, 10.1128/JVI.78.24.14043-14047.2004 · DOI · Paper page
  19. Nicholls, 2003, Lung pathology of fatal severe acute respiratory syndrome, Lancet, 361, 1773, 10.1016/S0140-6736(03)13413-7 · DOI · Paper page
  20. Wong, 2004, Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome, Clin Exp Immunol, 136, 95, 10.1111/j.1365-2249.2004.02415.x · DOI · Paper page
  21. Channappanavar, 2016, Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice, Cell Host Microbe, 19, 181, 10.1016/j.chom.2016.01.007 · DOI · Paper page
  22. Tang, 2008, IL-12 RB1 genetic variants contribute to human susceptibility to severe acute respiratory syndrome infection among Chinese, PLoS One, 3, e2183, 10.1371/journal.pone.0002183 · DOI
  23. Ip, 2005, Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection, J Infect Dis, 191, 1697, 10.1086/429631 · DOI · Paper page
  24. Franks, 2003, Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore, Hum Pathol, 34, 743, 10.1016/S0046-8177(03)00367-8 · DOI · Paper page
  25. Tse, 2004, Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS), J Clin Pathol, 57, 260, 10.1136/jcp.2003.013276 · DOI · Paper page
  26. Hsu, 2003, Severe acute respiratory syndrome in Singapore: clinical features of index patient and initial contacts, Emerg Infect Dis, 9, 713, 10.3201/eid0906.030264 · DOI · Paper page
  27. Booth, 2003, Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area, JAMA, 289, 2801, 10.1001/jama.289.21.JOC30885 · DOI · Paper page
  28. Peiris, 2003, The severe acute respiratory syndrome, N Engl J Med, 349, 2431, 10.1056/NEJMra032498 · DOI · Paper page
  29. Wong, 2004, Index patient and SARS outbreak in Hong Kong, Emerg Infect Dis, 10, 339, 10.3201/eid1002.030645 · DOI
  30. Yu, 2005, Temporal-spatial analysis of Severe acute respiratory syndrome among hospital inpatients, Clin Infect Dis, 40, 1237, 10.1086/428735 · DOI · Paper page
  31. Loon, 2004, The severe acute respiratory syndrome coronavirus in tears, Br J Ophthalmol, 88, 861, 10.1136/bjo.2003.035931 · DOI · Paper page
  32. Yu, 2004, Evidence of airborne transmission of the severe acute respiratory syndrome virus, N Engl J Med, 350, 1731, 10.1056/NEJMoa032867 · DOI · Paper page
  33. Chu, 2005, Viral load distribution in SARS outbreak, Emerg Infect Dis, 11, 1882, 10.3201/eid1112.040949 · DOI
  34. Yu, 2014, Severe acute respiratory syndrome beyond Amoy Gardens: completing the incomplete legacy, Clin Infect Dis, 58, 683, 10.1093/cid/cit797 · DOI
  35. Booth, 2005, Detection of airborne Severe acute respiratory syndrome (SARS) coronavirus and environmental contamination in SARS outbreak units, J Infect Dis, 191, 1472, 10.1086/429634 · DOI · Paper page
  36. Leung, 2004, The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients, Ann Intern Med, 141, 662, 10.7326/0003-4819-141-9-200411020-00006 · DOI · Paper page
  37. Peiris, 2003, Coronavirus as a possible cause of severe acute respiratory syndrome, Lancet, 361, 1319, 10.1016/S0140-6736(03)13077-2 · DOI · Paper page
  38. Leung, 2003, Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection, Gastroenterol, 125, 1011, 10.1016/j.gastro.2003.08.001 · DOI · Paper page
  39. Hung, 2003, Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome, Clin Chem, 49, 2108, 10.1373/clinchem.2003.025437 · DOI · Paper page
  40. Lau, 2004, Possible central nervous system infection by SARS coronavirus, Emerg Infect Dis, 10, 342, 10.3201/eid1002.030638 · DOI · Paper page
  41. Wong, 2003, Severe acute respiratory syndrome (SARS) in a geriatric patient with a hip fracture. A case report, J Bone Joint Surg Am, 85A, 1339, 10.2106/00004623-200307000-00022 · DOI
  42. Hon, 2003, Clinical presentations and outcome of severe acute respiratory syndrome in children, Lancet, 561, 1701, 10.1016/S0140-6736(03)13364-8 · DOI · Paper page
  43. Wong, 2004, Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome, Am J Obstet Gynecol, 191, 292, 10.1016/j.ajog.2003.11.019 · DOI · Paper page
  44. Leung, 2006, Seroprevalence of IgG antibodies to SARS-coronavirus in asymptomatic or subclinical population groups, Epidemiol Infect, 134, 211, 10.1017/S0950268805004826 · DOI · Paper page
  45. Hui, 2004, Severe Acute Respiratory Syndrome (SARS): correlation of clinical outcome and radiological features, Radiology, 233, 579, 10.1148/radiol.2332031649 · DOI
  46. Hui, 2003, Severe acute respiratory syndrome: clinical features and diagnosis, Respirol, 8, S20, 10.1046/j.1440-1843.2003.00520.x · DOI
  47. Wong, 2003, Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis, Br Med J, 326, 1358, 10.1136/bmj.326.7403.1358 · DOI · Paper page
  48. Wong, 2003, Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients, Radiology, 228, 401, 10.1148/radiol.2282030593 · DOI · Paper page
  49. Stroher, 2004, Severe acute respiratory syndrome-related coronavirus is inhibited by interferon-α, J Infect Dis, 189, 1164, 10.1086/382597 · DOI · Paper page
  50. Chu, 2004, Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings, Thorax, 59, 252, 10.1136/thorax.2003.012658 · DOI · Paper page
  51. Chan, 2003, Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicenter retrospective matched cohort study, Hong Kong Med J, 9, 399
  52. Cinatl, 2003, Treatment of SARS with human interferons, Lancet, 362, 293, 10.1016/S0140-6736(03)13973-6 · DOI · Paper page
  53. Hensley, 2004, Interferon-β 1a and SARS coronavirus replication, Emerg Infect Dis, 10, 317, 10.3201/eid1002.030482 · DOI · Paper page
  54. Haagmans, 2004, Pegylated interferon-α protects type 1 pneumocytes against SARS coronavirus infection in macaques, Nat Med, 10, 290, 10.1038/nm1001 · DOI · Paper page
  55. Loutfy, 2003, Interferon Alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study, JAMA, 290, 3222, 10.1001/jama.290.24.3222 · DOI · Paper page
  56. Jiang, 2005, Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome, Am J Respir Crit Care Med, 171, 850, 10.1164/rccm.200407-857OC · DOI · Paper page
  57. Sung, 2004, Severe Acute Respiratory Syndrome: report of treatment and outcome after a major outbreak, Thorax, 59, 414, 10.1136/thx.2003.014076 · DOI · Paper page
  58. Tsang, 2003, Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality, Emerg Infect Dis, 9, 1381, 10.3201/eid0911.030400 · DOI
  59. Wang, 2003, Fatal aspergillosis in a patient with SARS who was treated with corticosteroids, N Engl J Med, 349, 507, 10.1056/NEJM200307313490519 · DOI · Paper page
  60. Griffith, 2005, Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids, Radiology, 235, 168, 10.1148/radiol.2351040100 · DOI · Paper page
  61. Lee, 2004, Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients, J Clin Virol, 31, 304, 10.1016/j.jcv.2004.07.006 · DOI · Paper page
  62. Soo, 2004, Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients, Clin Microbiol Infect, 10, 676, 10.1111/j.1469-0691.2004.00956.x · DOI · Paper page
  63. Cheng, 2005, Use of convalescent plasma therapy in SARS patients in Hong Kong, Eur J Clin Microbiol Infect Dis, 24, 44, 10.1007/s10096-004-1271-9 · DOI · Paper page
  64. Mair-Jenkins, 2015, The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis, J Infect Dis, 211, 80, 10.1093/infdis/jiu396 · DOI · Paper page
  65. Yu, 2007, Why did outbreaks of severe acute respiratory syndrome occur in some hospital wards but not in others?, Clin Infect Dis, 44, 1017, 10.1086/512819 · DOI · Paper page
  66. Tran, 2012, Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review, PLoS One, 7, e35797, 10.1371/journal.pone.0035797 · DOI · Paper page
  67. Zaki, 2012, Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia, N Engl J Med, 367, 1814, 10.1056/NEJMoa1211721 · DOI · Paper page
  68. World Health Organization, 2016, Middle East Respiratory Syndrome Coronavirus (MERS-CoV) – Qatar, Disease Outbreak News
  69. Annan, 2013, Human betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and Europe, Emerg Infect Dis, 19, 456, 10.3201/eid1903.121503 · DOI · Paper page
  70. Memish, 2013, Middle East respiratory syndrome coronavirus in bats, Saudi Arabia, Emerg Infect Dis, 19, 1819, 10.3201/eid1911.131172 · DOI · Paper page
  71. Miguel, 2016, Absence of Middle East respiratory syndrome coronavirus in Camelids, Kazakhstan, 2015, Emerg Infect Dis, 22, 555, 10.3201/eid2203.151284 · DOI
  72. Chan, 2015, Absence of MERS-coronavirus in bactrian camels, southern Mongolia, November 2014, Emerg Infect Dis, 21, 1269, 10.3201/eid2107.150178 · DOI
  73. Hemida, 2014, Seroepidemiology of Middle East Respiratory Syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity, Euro Surveill, 19, 10.2807/1560-7917.ES2014.19.23.20828 · DOI
  74. Hemida, 2015, Dromedary camels and the transmission of Middle East Respiratory Syndrome Coronavirus (MERS-CoV), Transbound Emerg Dis, 10.3201/eid2104.141949 · DOI
  75. Hijawi, 2013, Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation, East Mediterr Health J, 19, S12, 10.26719/2013.19.supp1.S12 · DOI · Paper page
  76. Alraddadi, 2016, Risk factors for primary Middle East respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014, Emerg Infect Dis, 22, 49, 10.3201/eid2201.151340 · DOI · Paper page
  77. Drosten, 2014, Transmission of MERS-coronavirus in household contacts, N Engl J Med, 371, 828, 10.1056/NEJMoa1405858 · DOI · Paper page
  78. Arwady, 2016, Middle East respiratory syndrome coronavirus transmission in extended family, Saudi Arabia, 2014, Emerg Infect Dis, 22, 1395, 10.3201/eid2208.152015 · DOI · Paper page
  79. Müller, 2015, Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study, Lancet Infect Dis, 15, 559, 10.1016/S1473-3099(15)70090-3 · DOI · Paper page
  80. Oboho, 2015, 2014 MERS-CoV outbreak in Jeddah–a link to health care facilities, N Engl J Med, 372, 846, 10.1056/NEJMoa1408636 · DOI · Paper page
  81. Hunter, 2016, Transmission of Middle East respiratory syndrome coronavirus infections in healthcare settings, Abu Dhabi, Emerg Infect Dis, 22, 647, 10.3201/eid2204.151615 · DOI · Paper page
  82. Korea Centers for Disease Control and Prevention, 2015, Middle east respiratory syndrome coronavirus outbreak in the Republic of Korea, 2015, Osong Public Health Res Perspect, 6, 269, 10.1016/j.phrp.2015.08.006 · DOI · Paper page
  83. Oh, 2015, Middle east respiratory sayndrome coronavirus superspreading event involving 81 persons, Korea 2015, J Korean Med Sci, 30, 1701, 10.3346/jkms.2015.30.11.1701 · DOI · Paper page
  84. Zumla, 2014, Infection control and MERS-CoV in health-care workers, Lancet, 383, 1869, 10.1016/S0140-6736(14)60852-7 · DOI
  85. 2013, State of knowledge and data gaps of Middle East respiratory syndrome coronavirus (MERS-CoV) in humans, PLoS Curr, 5
  86. Guery, 2013, Clinical features and viral diagnosis of two cases of infection with middle east respiratory syndrome coronavirus: a report of nosocomial transmission, Lancet, 381, 2265, 10.1016/S0140-6736(13)60982-4 · DOI · Paper page
  87. Memish, 2013, Family cluster of middle east respiratory syndrome coronavirus infections, N Engl J Med, 368, 2487, 10.1056/NEJMoa1303729 · DOI · Paper page
  88. Algahtani, 2016, Neurological complications of middle east respiratory syndrome coronavirus: a report of two cases and review of the literature, Case Rep Neurol Med, 2016, 3502683
  89. Assiri, 2016, Middle east respiratory syndrome coronavirus infection during pregnancy: a report of 5 cases from Saudi Arabia, Clin Infect Dis, 63, 951, 10.1093/cid/ciw412 · DOI
  90. Alserehi, 2016, Impact of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) on pregnancy and perinatal outcome, BMC Infect Dis, 16, 105, 10.1186/s12879-016-1437-y · DOI · Paper page
  91. Malik, 2016, Middle east respiratory syndrome- coronavirus during pregnancy, Abu Dhabi, United Arab Emirates, 2013, Emerg Infect Dis, 22, 515, 10.3201/eid2203.151049 · DOI
  92. Payne, 2014, Stillbirth during infection with Middle East respiratory syndrome coronavirus, J Infect Dis, 209, 1870, 10.1093/infdis/jiu068 · DOI
  93. Drosten, 2013, Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection, Lancet Infect Dis, 13, 745, 10.1016/S1473-3099(13)70154-3 · DOI · Paper page
  94. Corman, 2016, Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection, Clin Infect Dis, 62, 477, 10.1093/cid/civ951 · DOI · Paper page
  95. Ajlan, 2014, Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings, AJR Am J Roentgenol, 203, 782, 10.2214/AJR.14.13021 · DOI · Paper page
  96. Lu, 2013, Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26, Nature, 500, 227, 10.1038/nature12328 · DOI · Paper page
  97. Müller, 2012, Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines, MBio, 3, 10.1128/mBio.00515-12 · DOI · Paper page
  98. Chan, 2013, Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation, J Infect Dis, 207, 1743, 10.1093/infdis/jit123 · DOI · Paper page
  99. de Wilde, 2013, MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment, J Gen Virol, 94, 1749, 10.1099/vir.0.052910-0 · DOI · Paper page
  100. Falzarano, 2013, Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin, Sci Rep, 3, 1686, 10.1038/srep01686 · DOI · Paper page
  101. Chan, 2013, Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures, J Virol, 87, 6604, 10.1128/JVI.00009-13 · DOI · Paper page
  102. Hocke, 2013, Emerging human middle east respiratory syndrome coronavirus causes widespread infection and alveolar damage in human lungs, Am J Respir Crit Care Med, 188, 882, 10.1164/rccm.201305-0954LE · DOI
  103. Faure, 2014, Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?, PLoS One, 9, e88716, 10.1371/journal.pone.0088716 · DOI · Paper page
  104. Poissy, 2014, Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases, J Clin Virol, 61, 275, 10.1016/j.jcv.2014.07.002 · DOI
  105. Park, 2015, Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea, Emerg Infect Dis, 21, 2186, 10.3201/eid2112.151421 · DOI · Paper page
  106. Payne, 2016, Persistence of antibodies against middle east respiratory syndrome coronavirus, Emerg Infect Dis, 22, 1824, 10.3201/eid2210.160706 · DOI · Paper page
  107. Ng, 2016, Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of middle east respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014, Am J Pathol, 186, 652, 10.1016/j.ajpath.2015.10.024 · DOI · Paper page
  108. Cha, 2016, A case report of a Middle East respiratory syndrome survivor with kidney biopsy results, J Korean Med Sci, 31, 635, 10.3346/jkms.2016.31.4.635 · DOI
  109. Zhou, 2014, Active replication of middle east respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis, J Infect Dis, 209, 1331, 10.1093/infdis/jit504 · DOI · Paper page
  110. Dyall, 2014, Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection, Antimicrob Agents Chemother, 58, 4885, 10.1128/AAC.03036-14 · DOI · Paper page
  111. De Wilde, 2014, Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture, Antimicrob Agents Chemother, 58, 4875, 10.1128/AAC.03011-14 · DOI · Paper page
  112. Falzarano, 2013, Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques, Nat Med, 19, 1313, 10.1038/nm.3362 · DOI · Paper page
  113. Al-Tawfiq, 2014, Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study, Int J Infect Dis, 20, 42, 10.1016/j.ijid.2013.12.003 · DOI · Paper page
  114. Shalhoub, 2015, IFN-α2a or IFN-β1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study, J Antimicrob Chemother, 70, 2129, 10.1093/jac/dkv085 · DOI · Paper page
  115. Omrani, 2014, Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study, Lancet Infect Dis, 14, 1090, 10.1016/S1473-3099(14)70920-X · DOI · Paper page
  116. Spanakis, 2014, Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen, Int J Antimicrob Agents, 44, 528, 10.1016/j.ijantimicag.2014.07.026 · DOI
  117. Rossignol, 2014, Nitazoxanide: a first-in-class broad-spectrum antiviral agent, Antiviral Res, 110, 94, 10.1016/j.antiviral.2014.07.014 · DOI · Paper page
  118. Arabi, 2014, Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection, Ann Intern Med, 160, 389, 10.7326/M13-2486 · DOI · Paper page
  119. Hui, 2013, Adjunctive therapies and immunomodulatory agents in the management of severe influenza, Antiviral Res, 98, 410, 10.1016/j.antiviral.2013.03.019 · DOI
  120. Chan, 2013, Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus, J Infect, 67, 606
  121. Chan, 2015, Treatment with lopinavir/ritonavir or interferon-β1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset, J Infect Dis, 212, 1904, 10.1093/infdis/jiv392 · DOI · Paper page
  122. AlGhamdi, 2015, MERS CoV infection in two renal transplant recipients: case report, Am J Transplant, 15, 1101, 10.1111/ajt.13085 · DOI
  123. Johnson, 2016, 3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012, Virology, 490, 49, 10.1016/j.virol.2016.01.004 · DOI · Paper page
  124. Corti, 2015, Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus, Proc Natl Acad Sci U S A, 112, 10473, 10.1073/pnas.1510199112 · DOI · Paper page
  125. Jiang, 2014, Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein, Sci Transl Med, 6, 234ra59, 10.1126/scitranslmed.3008140 · DOI · Paper page
  126. Luke, 2016, Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo, Sci Transl Med, 8, 326ra21, 10.1126/scitranslmed.aaf1061 · DOI · Paper page
  127. Johnson, 2015, Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease, Virology, 485, 422, 10.1016/j.virol.2015.07.013 · DOI · Paper page
  128. Breban, 2013, Interhuman transmissibility of middle east respiratory syndrome coronavirus: estimation of pandemic risk, Lancet, 382, 694, 10.1016/S0140-6736(13)61492-0 · DOI · Paper page
  129. Hui, 2014, Advancing priority research on the middle east respiratory syndrome coronavirus, J Infect Dis, 209, 173, 10.1093/infdis/jit591 · DOI

Cited by

Metadata

Authors
Hui, D. S.
Venue
Clinics in Chest Medicine
Publisher
Elsevier BV
Published
2017-03
Volume
38
Issue
1
Pages
71-86
ISSN
0272-5231 (ISSN-L)
OpenAlex
W2564025375
Cited by
153
References
12
FWCI
1.68
Type
journal article
Language
en
Open access
green
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.